Your browser doesn't support javascript.
loading
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
Kropff, Jort; Del Favero, Simone; Place, Jerome; Toffanin, Chiara; Visentin, Roberto; Monaro, Marco; Messori, Mirko; Di Palma, Federico; Lanzola, Giordano; Farret, Anne; Boscari, Federico; Galasso, Silvia; Magni, Paolo; Avogaro, Angelo; Keith-Hynes, Patrick; Kovatchev, Boris P; Bruttomesso, Daniela; Cobelli, Claudio; DeVries, J Hans; Renard, Eric; Magni, Lalo.
Affiliation
  • Kropff J; Department of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. Electronic address: j.kropff@amc.nl.
  • Del Favero S; Department of Information Engineering, University of Padova, Padova, Italy.
  • Place J; Department of Endocrinology, Diabetes, Nutrition Montpellier University Hospital, INSERM Clinical Investigation Centre 1411, and Institute of Functional Genomics, CNRS UMR 5203, INSERM U1191, University of Montpellier, Montpellier, France.
  • Toffanin C; Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.
  • Visentin R; Department of Information Engineering, University of Padova, Padova, Italy.
  • Monaro M; Department of Information Engineering, University of Padova, Padova, Italy.
  • Messori M; Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.
  • Di Palma F; Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.
  • Lanzola G; Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
  • Farret A; Department of Endocrinology, Diabetes, Nutrition Montpellier University Hospital, INSERM Clinical Investigation Centre 1411, and Institute of Functional Genomics, CNRS UMR 5203, INSERM U1191, University of Montpellier, Montpellier, France.
  • Boscari F; Unit of Metabolic Diseases, Department of Internal Medicine-DIM, University of Padova, Padova, Italy.
  • Galasso S; Unit of Metabolic Diseases, Department of Internal Medicine-DIM, University of Padova, Padova, Italy.
  • Magni P; Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy; Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.
  • Avogaro A; Unit of Metabolic Diseases, Department of Internal Medicine-DIM, University of Padova, Padova, Italy.
  • Keith-Hynes P; Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.
  • Kovatchev BP; Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.
  • Bruttomesso D; Unit of Metabolic Diseases, Department of Internal Medicine-DIM, University of Padova, Padova, Italy.
  • Cobelli C; Department of Information Engineering, University of Padova, Padova, Italy.
  • DeVries JH; Department of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Renard E; Department of Endocrinology, Diabetes, Nutrition Montpellier University Hospital, INSERM Clinical Investigation Centre 1411, and Institute of Functional Genomics, CNRS UMR 5203, INSERM U1191, University of Montpellier, Montpellier, France.
  • Magni L; Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy; Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.
Lancet Diabetes Endocrinol ; 3(12): 939-47, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26432775
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas, Artificial / Diabetes Mellitus, Type 1 / Hyperglycemia / Hypoglycemia / Hypoglycemic Agents / Insulin Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Diabetes Endocrinol Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas, Artificial / Diabetes Mellitus, Type 1 / Hyperglycemia / Hypoglycemia / Hypoglycemic Agents / Insulin Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Diabetes Endocrinol Year: 2015 Type: Article